They made the first anti-VEGF drug 20+ years ago. Now two longtime partners have $65M to spot new eye drugs
Almost 30 years ago, when David Guyer and Anthony Adamis were still medical school professors — at New York University and Harvard, respectively — the duo began working together on ways to prevent vision loss by blocking the formation of blood vessels in the eye. Their work ultimately culminated in the first ever intraocular anti-VEGF injection, approved by the FDA in 2004 for wet age-related macular degeneration.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
